Literature DB >> 853125

Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.

E D Zanjani, J D Lutton, R Hoffman, L R Wasserman.   

Abstract

In the plasma clot culture system both normal and polycythemia vera (PV) bone marrow cells respond to erythropoietin (Ep), giving rise to large numbers of colonies of erythroid cells. In PV, but not in normal individuals, the marrow produced endogenous erythroid colonies (EED) in the absence of exogenous Ep. The number of EEC formed varied from patient to patient comprising anywhere from 6 to 29% of the total number of colonies formed in the presence of Ep. Exposure, before use in culture, of fetal calf serum and citrated bovine plasma to the gammaglobulin fraction of rabbit anti-Ep serum followed by treatment with goat anti-rabbit gamma-globulin re sulted in a significant decrease in EEC formation. Addition of anti-Ep directly to the culture medium produced similar results. In addition, the production of EEC in response to added Ep was inhibited in the presence of anti-Ep. Addition of very small doses of highly purified Ep to anti-Ep-treated cultures resulted in the reappearance of a significantnumber of EEC formation in PV may be due to a population of erythroid-committed precursors that are abnormally sensitive to small concentrations of Ep which may be present in fetal calf serum and citrated plasma. Although the mechanism of formation of these cells is not known, it appears that the final steps in the formation of red cells derived from this clone of precursors is subject to the usual Ep control.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 853125      PMCID: PMC372292          DOI: 10.1172/JCI108706

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  USE OF THE HYPOXIA-INDUCED POLYCYTHEMIC MOUSE IN THE ASSAY AND STANDARDIZATION OF ERYTHROPOIETIN.

Authors:  A H WEINTRAUB; A S GORDON; J F CAMISCOLI
Journal:  J Lab Clin Med       Date:  1963-11

2.  SOME PROPERTIES OF SERUM OBTAINED FROM RABBITS IMMUNIZED WITH HUMAN URINARY ERYTHROPOIETIN.

Authors:  J C SCHOOLEY; J F GARCIA
Journal:  Blood       Date:  1965-02       Impact factor: 22.113

3.  Hematopoietic factors in polycythemia vera.

Authors:  E D Zanjani
Journal:  Semin Hematol       Date:  1976-01       Impact factor: 3.851

4.  A summary of some studies on erythropoiesis using anti-erythropoietin immune serum.

Authors:  J C Schooley; J F Garcia; L N Cantor; V W Havens
Journal:  Ann N Y Acad Sci       Date:  1968-03-29       Impact factor: 5.691

5.  Erythropietic colonies in cultures of human marrow.

Authors:  A D Tepperman; J E Curtis; E A McCulloch
Journal:  Blood       Date:  1974-11       Impact factor: 22.113

6.  Bone marrow response to erythropoietin in polycythemia vera and chronic granulocytic leukemia.

Authors:  S Zucker; D M Howe; L R Weintraub
Journal:  Blood       Date:  1972-03       Impact factor: 22.113

7.  Case report: studies on the mechanism of erythrocytosis associated with a uterine fibromyoma.

Authors:  A L Ossias; E D Zanjani; R Zalusky; S Estren; L R Wasserman
Journal:  Br J Haematol       Date:  1973-08       Impact factor: 6.998

8.  Letter: Bone-marrow responses in polycythemia vera.

Authors:  J F Prchal; A A Axelrad
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

9.  The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation.

Authors:  J W Adamson
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

Review 10.  Erythropoietin.

Authors:  A S Gordon
Journal:  Vitam Horm       Date:  1973       Impact factor: 3.421

View more
  30 in total

Review 1.  The molecular mechanisms that control thrombopoiesis.

Authors:  Kenneth Kaushansky
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  Myeloproliferative disorders.

Authors:  Ross L Levine; D Gary Gilliland
Journal:  Blood       Date:  2008-09-15       Impact factor: 22.113

3.  Circulating hematopoietic progenitor cells in polycythemia vera: the in vivo effect of hydroxyurea.

Authors:  G Castello; R Lerza; A Cerruti; D Cavallini; G Bogliolo; I Pannacciulli
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

4.  Erythrocytosis caused by an erythropoietin-producing breast adenocarcinoma.

Authors:  R F Bohnen; M Banisadre; R N Gulbrandson; E D Zanjani
Journal:  West J Med       Date:  1990-04

5.  Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin.

Authors:  K Sawada; S B Krantz; J S Kans; E N Dessypris; S Sawyer; A D Glick; C I Civin
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

6.  Erythropoietin receptors in polycythemia vera.

Authors:  R T Means; S B Krantz; S T Sawyer; H S Gilbert
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity.

Authors:  R P Hebbel; J W Eaton; R S Kronenberg; E D Zanjani; L G Moore; E M Berger
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.

Authors:  J F Prchal; J W Adamson; S Murphy; L Steinmann; P J Fialkow
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

9.  In vitro studies of human pluripotential hematopoietic progenitors in polycythemia vera. Direct evidence of stem cell involvement.

Authors:  R C Ash; R A Detrick; E D Zanjani
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

10.  Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.

Authors:  M T Mitjavila; J P Le Couedic; N Casadevall; S Navarro; J L Villeval; A Dubart; W Vainchenker
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.